CN104830820A - Protease and detection method for rapidly detecting ribonucleic acid at constant room temperature - Google Patents

Protease and detection method for rapidly detecting ribonucleic acid at constant room temperature Download PDF

Info

Publication number
CN104830820A
CN104830820A CN201510229119.0A CN201510229119A CN104830820A CN 104830820 A CN104830820 A CN 104830820A CN 201510229119 A CN201510229119 A CN 201510229119A CN 104830820 A CN104830820 A CN 104830820A
Authority
CN
China
Prior art keywords
leu
lys
ala
asp
glu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510229119.0A
Other languages
Chinese (zh)
Inventor
程奇
周国辉
李贤祯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ZHEJIANG TAIJING BIOTECHNOLOGY CO Ltd
Original Assignee
ZHEJIANG TAIJING BIOTECHNOLOGY CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ZHEJIANG TAIJING BIOTECHNOLOGY CO Ltd filed Critical ZHEJIANG TAIJING BIOTECHNOLOGY CO Ltd
Priority to CN201510229119.0A priority Critical patent/CN104830820A/en
Publication of CN104830820A publication Critical patent/CN104830820A/en
Pending legal-status Critical Current

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention discloses protease for rapidly detecting ribonucleic acid at a constant room temperature. The protease comprises (1) reverse transcriptase (SEQ ID No.17); (2) recombinase (SEQ ID No.18); (3) single-chain binding protein (SEQ ID No.19); (4) DNA polymerase (SEQ ID No.20); and (5) auxiliary protein (SEQ ID No.21). The invention also discloses a reagent and detection method for rapidly detecting ribonucleic acid at a constant room temperature. In the provided detection method, the RNA amplification is imitated in-vitro by using the disclosed multiple gene engineering enzymes and chemical components; the RNA amplification and detection can be finished in one step rapidly at a constant room temperature through the interactions among the components; and thus the detection of viral pathogen becomes more convenient and rapid.

Description

For proteolytic enzyme and the detection method of normal temperature isothermal rapid detection Yeast Nucleic Acid
Technical field
The present invention is a new opplication of nucleic acid isothermal amplification technology, relate to and utilize several genes engineering enzyme and chemical composition to simulate in vitro, by the interaction between them, realize under normal temperature isothermal condition, fast, amplification and the testing process of Yeast Nucleic Acid (RNA) is completed to single stage method, thus make the detection of virus type pathogenic agent more fast with easier, thus can more effectively be applied to from now in the middle of MicroRNA detection or on-site rapid inspection quarantine field.
Background technology
After polymerase chain reaction (PCR) helps to realize the amplification in vitro of thymus nucleic acid (DNA), the amplification in vitro of RNA also causes the concern of scientists thereupon, and therefore deriving technology reverse transcription PCR (RT-PCR) also just arises.Initial reverse transcription PCR, with two-step approach, namely becomes cDNA by RNA reverse transcription, is that template carries out standard PCR amplification afterwards again, thus realizes amplification or the detection of RNA with cDNA.But along with the needs developed, loaded down with trivial details two-step approach can not meet the demand of inspection and quarantine task well, the single stage method RNA amplification thereupon occurred, has carried out depth optimization by required for reaction component, has achieved the augmentation detection from RNA template to product D NA in same reaction tubes.However, PCR highly relies on the shortcoming that accurate temperature cycler carries out detecting, and is confined in centralab by the detection of RNA, also limit the ability of its rapid detection virus type pathogenic agent at the scene to a great extent.
In the nucleic acid isothermal amplification technology gone from strength to strength in recent years, also advantage and ability that some technology possesses Site Detection RNA aspect is no lack of, but because of the difference of Cleaning Principle, all emphasize particularly on different fields a little and strengths and weaknesses: 1) loop-mediated isothermal amplification technique (LAMP) utilizes 4 pairs of primer specific identifications, 6 target sites and has the Bst enzyme of strand-displacement activity, nucleic acid can be realized under 60-65 degree condition, comprise the rapid detection (<60 minute) of DNA and RNA; 2) amplification (NASBA) method of nucleotide sequence is depended on, utilize the mediation of three kinds of enzymes (AMV reversed transcriptive enzyme, RNaseH and t7 rna polymerase) and two Auele Specific Primers, incubation 1.5-2 hour under a steady temperature, can complete the enzymic process that RNA template increases fast; 3) rolling circle amplification (RCA), utilize DNA ligase and archaeal dna polymerase, with the pattern of rolling-circle replication, the strand displacement synthesis of annular template is carried out from one or more primer, thus can the genomic amplification of ring-type of achievement unit partitivirus, but the reaction times of RCA, partially to grow the advantage that (>4 hour) make it at the scene in detection field just very unobvious; 4) single primer isothermal amplification technique (SPIA), under 55-65 degree, can realize the external linear isothermal amplification of DNA by the archaeal dna polymerase of the primer of a DNA-RNA heterozygosis, RNaseH and strong strand-displacement activity in 30 minutes; The reversed transcriptive enzyme added on this basis can help the isothermal duplication realizing RNA template, Ribo-SPIA by name; 5) the enzyme dna isothermal amplification technique (HDA) that untwists is relied on, then utilize helicase, DNA single chain binding protein, archaeal dna polymerase and heat-staple reversed transcriptive enzyme acting in conjunction, under 37 or 65 degree of (temperature depends on the archaeal dna polymerase of use) conditions, with the form of two-step approach or single stage method, the rapid amplifying (~ 120 minutes) of RNA template can be realized; 6) chain substitutes amplification (SDA) technology, is the external isothermal amplification technique of DNA deriving based on enzymatic reaction and obtain, and utilizes restriction endonuclease and the archaeal dna polymerase with strand-displacement activity, realizes the amplification of nucleic acid under isothermal conditions.
Because of virus cause susceptibility to disease and infectivity all very strong, therefore if any one fast and accurately method or technology can help through detecting of virus (containing DNA or RNA viruses) at the scene, effectively and in time can prevent diffusion and the propagation of virus disease.Given this, nucleic acid isothermal amplification technology should be current optimal technology kind, but existing mature technology or because of incubation temperature, such as 60-65 degree, still need to rely on specific incubation equipment, or because of the incubation time still factor such as relatively long, still there is a certain distance from really realizing Site Detection.Therefore, the invention is intended to provide a kind of more fast, be applicable to the technology of Site Detection RNA more accurately.
Summary of the invention
The present invention aims to provide one under normal temperature isothermal condition, fast, can complete the amplification of Yeast Nucleic Acid (RNA) and the method for detection to single stage method.
First object of the present invention is to provide the proteolytic enzyme for normal temperature isothermal rapid detection Yeast Nucleic Acid.
For the proteolytic enzyme of normal temperature isothermal rapid detection Yeast Nucleic Acid, it is characterized in that, described proteolytic enzyme comprises: (1) reversed transcriptive enzyme; (2) recombinase; (3) single strand binding protein; (4) archaeal dna polymerase; (5) accessory protein; The aminoacid sequence of described reversed transcriptive enzyme is as shown in SEQ ID No.17; The aminoacid sequence of recombinase is as shown in SEQ ID No.18; The aminoacid sequence of single strand binding protein is as shown in SEQ ID No.19; The aminoacid sequence of archaeal dna polymerase is as shown in SEQ ID No.20; The aminoacid sequence of accessory protein is as shown in SEQ ID No.21.
Normal temperature isothermal of the present invention, refers to and to hatch under a certain steady temperature, and temperature is 40-42 DEG C (being preferably 40 DEG C), close to normal temperature, and is homogeneous constant temp.
Reversed transcriptive enzyme, be a kind of proteolytic enzyme after adopting point mutation to carry out genetic modification, being characterized in: 1) have DNA polymerase activity, take RNA as template, and catalysis dNTP is polymerized generation complementary (cDNA); 2) by the active inactivation of RNaseH that point mutation will have originally, thus avoid the RNA in DNA-RNA heterozygosis chain to be hydrolyzed; 3) this enzyme sequence derives from murine leukemia reversed transcriptive enzyme (M-MLV), transforms by point mutation; 4) consumption in reaction system is about 8-12 unit/ul.
Recombinase, is a kind of engineered protein enzyme, is characterized in: 1) have the ability in conjunction with single strand dna, therefore can form initiation complex with primer tasteless nucleotide strand; 2) there is the ability combined with double chain DNA molecule, therefore also in conjunction with DNA double chain or DNA-RNA heterozygosis chain while formation initiation complex, thus the special triple strand dna intermediate of structure could be formed; 3) there is homologous recombination activity, when single stranded DNA invades double-stranded DNA or heterozygosis chain, after searching out homologous sequence area along chain, the strand of homology can be squeezed away, form Bubble Region, so-called local, and then facilitate the intervention of follow-up archaeal dna polymerase; 4) this enzyme sequence can derive from the RecA of intestinal bacteria (E.coli), or T4 phage recombinase uvsX, by genetic engineering modified further; 5) consumption in reaction system is about 100-150ng/ul.
Single strand binding protein, is a kind of DBP, is characterized in: 1) along the Bubble Region, local formed, locally combine the homology strand being replaced out, avoid it by nuclease degradation; 2) do not possess enzymic activity, the ATP that therefore gets along well combines; 3) there is synergistic effect, therefore can multiple single strand binding protein be adjacent is incorporated on DNA single chain, be convenient to the DNA synthesis of Bubble Region; 4) this combination has short-time characteristic, therefore constantly could combine along " replication fork ", again constantly assembly again; 5) this enzyme sequence can come from the gp32 albumen of E.coli or T4; 6) consumption in reaction system is about 700-1000ng/ul.
Archaeal dna polymerase, is a kind ofly rely on the engineered protein enzyme that DNA profiling carries out complementary dna sequence synthesis, is characterized in: 1) have higher continuous synthesis ability; 2) there is strand-displacement activity, while the new chain of synthesis, coordinate single strand binding protein to be continued to advance along " replication fork " direction in Bubble Region, local by strand displacement capability, thus homology chain is replaced out; 3) 3 '-5 is had ' excision enzyme (calibration capability) is active, thus the fidelity of guarantee synthesis; 4) non-refractory, reacts under being therefore highly suitable for normal temperature isothermal condition, and completes the synthesis of DNA chain; 5) sequence of this enzyme can come from the DNA polymerase i Klenow large fragment of E.coli, Bst polysaccharase, Phi-29 polysaccharase or Bacillus subtillis PolI (Bsu); 6) consumption in reaction system is about 60-90ng/ul.
Accessory protein, is a kind ofly assist or strengthen the albumen of recombinase active, is characterized in: 1) promote and stablize the combination of initiation complex and DNA double interchain; 2) the uvsY albumen of the optional T4 phage of sequence; 3) consumption in reaction system is about 20-40ng/ul.
Second object of the present invention is to provide the reagent for normal temperature isothermal rapid detection Yeast Nucleic Acid.
For the reagent of normal temperature isothermal rapid detection Yeast Nucleic Acid, it is characterized in that, described reagent mainly comprises Tris, RNase inhibitor, dNTP, ATP, disodium creatine phosphate, creatine phosphokinase, potassium acetate, trehalose, N.F,USP MANNITOL, polyoxyethylene glycol, dithiothreitol (DTT), amplimer and reversed transcriptive enzyme, recombinase, single strand binding protein, archaeal dna polymerase and accessory protein.
In described reagent, 5 kinds of albumen (enzyme) and other chemical composition prepare the optimal reaction environment of rear formation by a certain percentage: 5%PEG35000, 6% trehalose, the recombinase of 115ng/ul, the accessory protein of 35ng/ul, the single strand binding protein of 830ng/ul, the Bsu polysaccharase of 78ng/ul, the reversed transcriptive enzyme of 12 units/ul, the RNase inhibitor of 0.15 unit/ul, the ATP of 3.5mM, the dNTPs of 490uM, the Tris damping fluid of 55mM, the dithiothreitol (DTT) of 12mM, the disodium creatine phosphate of 12mM, the creatine phosphokinase of 114ng/ul, the potassium acetate of 75mM and 7% N.F,USP MANNITOL, the amplimer of 350-450nM, cumulative volume is 50ul.Detection reagent, through lyophilize process, removes liquid phase, retains solid matter, can be made into white dry powder, carry out resuspended when being convenient to field quick detection.Reaction reagent after frozen dried is white dry powder, is attached to tube wall without any viscous substance, after resuspended with damping fluid, can dissolve completely, exists without any obvious particulate material; After freeze-drying, the detection vigor of reaction system can maintain half a year.
Genetically engineered enzyme, specified chemical component and the primer utilizing function different for the reagent of normal temperature isothermal rapid detection Yeast Nucleic Acid of the present invention, can realize the amplification of RNA normal temperature.There is following characteristics: 1) genetically engineered enzyme wherein or albumen comprise 5 kinds, are reversed transcriptive enzyme, recombinase, single strand binding protein, archaeal dna polymerase and accessory protein respectively; 2) chemical composition comprises RNase inhibitor; The Triphosaden (ATP) of lasting ATP energy, disodium creatine phosphate (PCr) and creatine phosphokinase (CK) is provided to combine; The deoxyribonucleoside triphosphate (dNTP) of synthesis unit is provided; Maintain the potassium acetate (KAc) of reactive ion and potential of hydrogen environment, dithiothreitol (DTT) (DTT) and polyoxyethylene glycol (PEG); And the trehalose (Trehalose) of protein-active and N.F,USP MANNITOL (Mannitol) in maintenance freezing dry process; 3) primer is the oligonucleotide strand that a pair length is about 30-35nt, respectively the upstream and downstream of specific recognition target area.
3rd object of the present invention is to provide a kind of method of normal temperature isothermal rapid detection Yeast Nucleic Acid.
A method for normal temperature isothermal rapid detection Yeast Nucleic Acid, is characterized in that, after detection reagent adds template, being placed in a temperature control device, to maintain incubation temperature be 40-42 DEG C, hatches 20-40 minute, hatch in process and keep homogeneous steady temperature; Visual retrieval is carried out again by agarose gel electrophoresis; Described detection reagent mainly comprises Tris, RNase inhibitor, dNTP, ATP, disodium creatine phosphate, creatine phosphokinase, potassium acetate, trehalose, N.F,USP MANNITOL, polyoxyethylene glycol, dithiothreitol (DTT), amplimer, reversed transcriptive enzyme, recombinase, single strand binding protein, archaeal dna polymerase and accessory protein.
The present invention can realize on-the-spot RNA rapid detection.After the resuspended lyophilize reaction reagent system of damping fluid, a series of detection operations carried out at normal temperatures.Damping fluid (5-6%PEG), 350-450nM primer, template, distilled water and 12-15mM magnesium acetate (MgAc) is comprised for resuspended component.Total reaction volume is 50ul; The optional 40-42 degree of incubation temperature, optimum is 40 degree; Incubation time is 20-40 minute; Can also select to be added into a fluorescent probe or fluorescence dye, realize the real-time RNA rapid detection of normal temperature.
Temperature control device of the present invention is for reacting the instrument providing appropriate incubation environment, having temperature control modules, set of time function and sample well.Such as metal bath, water-bath, incubator or other small portable incubation equipment etc.
The present invention has following technical characterstic:
1) normal temperature isothermal: by 5 kinds of engineering enzymes create together with chemical composition one at utmost simulate biological nucleic acid in vivo increase environment, and often kind of engineering enzyme all Each performs its own functions, the temperature of reaction that it is the suitableeest works, and therefore working efficiency is the highest.
2) quick: because often kind of enzyme carries out work on optimal reactive temperature, therefore activity ensure that the quick of reaction efficiently.In addition, the cDNA that enzyme which catalyzes is complementary with it based on RNA template generation, and form with it the DNA-RNA heterozygosis chain be not degraded, this heterozygosis chain is as the template of following amplification subsequently.This RNase H activity digestion by reversed transcriptive enzyme more first than RT-PCR method generates strand cDNA, and it is rapider to carry out following amplification again with strand, more saves time, therefore reacts also quicker.
3) single stage method: all amplifications from RNA to DNA or reaction are all carried out in same reaction tubes, are also only completed by disposable application of sample, therefore operate simpler.
Accompanying drawing explanation
Fig. 1 is three pairs of primers electrophorogram when being template amplification with STb gene (gDNA) or soybean RNA respectively; In figure, swimming lane 1 is gDNA amplified production, and size is 343bp, and swimming lane 2 is RNA amplification product, and size is 251bp; Swimming lane 3 is gDNA amplified production, and size is 444bp, and swimming lane 4 is RNA amplification product, and size is 352bp; Swimming lane 5 is gDNA amplified production, and size is 449bp, and swimming lane 6 is RNA amplification product, and size is 164bp; Swimming lane 7 is gDNA amplified production, and size is 472bp, and swimming lane 8 is RNA amplification product, and size is 333bp; M is DNA marker thing.
Fig. 2 is primer pair E1-F/R electrophorogram when being template amplification with STb gene (gDNA) or soybean RNA respectively; In figure, swimming lane 1,2,3 is all gDNA amplified production, and size is 343bp, is three duplicate detection; Swimming lane 4 is RNA amplification products, and size is 251bp; M is DNA marker thing.
Fig. 3 be primer pair HSP-F/R and ACT-F/R respectively with paddy rice RNA for electrophorogram during template amplification; In figure, swimming lane 1,3 is negative controls; Swimming lane 2,4 is HSP amplified production (size is 120bp) and Actin amplified production (size is 121bp) respectively; M is DNA marker thing.
Fig. 4 be primer pair CAA3-F/R and BmG-F/R respectively with silkworm RNA for electrophorogram during template amplification; In figure, swimming lane 1,4 is negative control; Swimming lane 2,3 is the amplified production of gene cytoplasmic actin A3, and size is 176bp; Swimming lane 5,6 is the amplified production of gene BmGAPDH, and size is 172bp; M is DNA marker thing.
Embodiment
Following specific embodiment is further illustrating technique and method scheme provided by the invention, but does not should be understood to limitation of the present invention.
The biological material source used in the present invention:
1.RNA template derives from Soybean Leaves, paddy rice, silkworm respectively, uses traditional Trizol method to carry out extracting and obtaining in laboratory.
2.DNA template also derives from soybean, adopts traditional Total DNA extraction method to carry out extracting acquisition.
Amplification primers all with VectorNTI7.0 design, after win polygala root biotechnology limited liability company in Beijing three and synthesize and prepare.
Embodiment 1
The present embodiment successfully can carry out normal temperature isothermal RNA rapid detection for illustration of in soybean RNA template.
1. based on the reference gene EF1b (gi353336037) of soybean and the sequence of Actin-1-like (gi353336033), according to across intron principle, devise respectively 4 to 2 pairs of primers.After experiment, 3 pairs of primers are selected in EF1b, E1-F/R (SEQ ID No.1 & 2), E2-F/R (SEQ ID No.3 & 4) and E3-F/R (SEQ ID No.5 & 6) respectively.In Actin-1-like, select 1 pair of primer, be AL1-F/R (SEQ ID No.7 & 8).
E1-F:5’-CTTCTCGATGTTAAGCCTTGGGACGATG-3’(SEQ ID No.1)
E1-R:5’-TTGAATGCAACAATGTCACAGCTCTGGA-3’(SEQ ID No.2)
E2-F:5’-ATGAGACCGACATGAAGAAGCTGGAAGA-3’(SEQ ID No.3)
E2-R:5’-CACAATTCTTGCAAGAAAACCACCATTG-3’(SEQ ID No.4)
E3-F:5’-AGGAGGATAAGAAGGCAGCAGAGGAAAG-3’(SEQ ID No.5)
E3-R:5’-TAAACCAGGCATCTCAATACTACGGACA-3’(SEQ ID No.6)
AL1-F:5’-GTGTTTCCCAGCATTGTAGGTCGTCCTC-3’(SEQ ID No.7)
AL1-R:5’-ATAGGGACAGTGTGGCTGACACCATCAC-3’(SEQ ID No.8)
2. use the freeze-drying reaction system of preparation as main reaction composition, then add the components such as primer, damping fluid, distilled water, template and magnesium acetate, complete the preparation detecting liquid.5 kinds of albumen (enzyme) and other chemical composition prepare the optimal reaction environment of rear formation by a certain percentage: 5%PEG35000,6% trehalose, the recombinase of 115ng/ul, the accessory protein of 35ng/ul, the single strand binding protein of 830ng/ul, the Bsu polysaccharase of 78ng/ul, the reversed transcriptive enzyme of 12 units/ul, the RNase inhibitor of 0.15 unit/ul, the ATP of 3.5mM, the dNTPs of 490uM, the Tris damping fluid of 55mM, the dithiothreitol (DTT) of 12mM, the disodium creatine phosphate of 12mM, the creatine phosphokinase of 114ng/ul, the potassium acetate of 75mM and 7% N.F,USP MANNITOL; The amplimer of 350-450nM, cumulative volume is 50ul.
3. amplified reaction program: 40 degree of isothermals, 40 minutes.
4. last agarose gel electrophoresis carry out detecting (Fig. 1. and Fig. 2 .).Fig. 1 be three pairs of primers respectively with STb gene (gDNA) or soybean RNA be template increase time electrophorogram.Because primer is across intron design, therefore the amplified production of obvious gDNA is greater than the product of RNA, illustrates really to achieve to obtain product from RNA sample single stage method under normal temperature isothermal condition.Fig. 2 is primer pair E1-F/R electrophorogram when being template amplification with STb gene (gDNA) or soybean RNA respectively.
Embodiment 2
The present embodiment also successfully can carry out normal temperature isothermal RNA rapid detection for illustration of in the RNA template of paddy rice and silkworm.
1., based on the sequence of reference gene HSP and Actin of paddy rice, according to across intron principle, carry out design of primers respectively.By overtesting screening, obtain primer HSP-F/R (SEQ ID No.9 & 10) and ACT-F/R (SEQ ID No.11 & 12) respectively.
HSP-F:5’-CTCAACATCTCACGTGAGATGCTCCAGCAG-3’(SEQ ID No.9)
HSP-R:5’-GTTGTAGTCTTCCTTGTTCTCAGCGATCTC-3’(SEQ ID No.10)
ACT-F:5’-GCTATGTACGTCGCCATCCAGGCCGTCCTCTC-3’(SEQ ID No.11)
ACT-R:5’-GAGCATATCCTTCATAGATGGGGACAGTGTG-3’(SEQ ID No.12)
2. based on the sequence of reference gene cytoplasmic actin A3 and BmGAPDH of silkworm, according to across intron principle of design, design and screened primer CAA3-F/R (SEQ ID No.13 & 14) and BmG-F/R (SEQ ID No.15 & 16) respectively.
CAA3-F:5’-GCCATCAGGGCGTGATGGTCGGCATGGGACAGAAG-3’(SEQ ID No.13)
CAA3-R:5’-GGCGACACGCAGCTCATTGTAGAAGGTATGATGCC-3’(SEQ ID No.14)
BmG-F:5’-CATCATTCCTGCCTCTACTGGTGCTGCCAAAG-3’(SEQ ID No.15)
BmG-R:5’-GACCTTTTGCTTGATGGCTTCATAGCTTGCAG-3’(SEQ ID No.16)
3. use the freeze-drying reaction system of preparation as main reaction composition, then add the components such as primer, damping fluid, distilled water, template and magnesium acetate, complete the preparation detecting liquid.5 kinds of albumen (enzyme) and other chemical composition prepare the optimal reaction environment of rear formation by a certain percentage: 5%PEG35000,6% trehalose, the recombinase of 115ng/ul, the accessory protein of 35ng/ul, the single strand binding protein of 830ng/ul, the Bsu polysaccharase of 78ng/ul, the reversed transcriptive enzyme of 12 units/ul, the RNase inhibitor of 0.15 unit/ul, the ATP of 3.5mM, the dNTPs of 490uM, the Tris damping fluid of 55mM, the dithiothreitol (DTT) of 12mM, the disodium creatine phosphate of 12mM, the creatine phosphokinase of 114ng/ul, the potassium acetate of 75mM and 7% N.F,USP MANNITOL; The amplimer of 350-450nM, cumulative volume is 50ul.
4. amplified reaction program: 40 degree of isothermals, 40 minutes.
5. last agarose gel electrophoresis carry out detecting (Fig. 3. and Fig. 4 .).Fig. 3 be primer pair HSP-F/R and ACT-F/R respectively with paddy rice RNA for electrophorogram during template amplification.Fig. 4 be primer pair CAA3-F/R and BmG-F/R respectively with silkworm RNA for electrophoresis during template amplification.Two figure illustrate that this one step method ribonucleic acid TRAP is applicable to plant origin RNA, are also applicable to animal-origin RNA, possess methodology pardon.
SEQUENCE LISTING
 
<110> Zhejiang Taijing Biotechnology Co., Ltd.
 
<120> is used for proteolytic enzyme and the detection method of normal temperature isothermal rapid detection Yeast Nucleic Acid
 
<130>
 
<160> 21
 
<170> PatentIn version 3.3
 
<210> 1
<211> 28
<212> DNA
<213> artificial sequence
 
<400> 1
cttctcgatg ttaagccttg ggacgatg 28
 
<210> 2
<211> 28
<212> DNA
<213> artificial sequence
 
<400> 2
ttgaatgcaa caatgtcaca gctctgga 28
 
<210> 3
<211> 28
<212> DNA
<213> artificial sequence
 
<400> 3
atgagaccga catgaagaag ctggaaga 28
 
<210> 4
<211> 28
<212> DNA
<213> artificial sequence
 
<400> 4
cacaattctt gcaagaaaac caccattg 28
 
<210> 5
<211> 28
<212> DNA
<213> artificial sequence
 
<400> 5
aggaggataa gaaggcagca gaggaaag 28
 
<210> 6
<211> 28
<212> DNA
<213> artificial sequence
 
<400> 6
taaaccaggc atctcaatac tacggaca 28
 
<210> 7
<211> 28
<212> DNA
<213> artificial sequence
 
<400> 7
gtgtttccca gcattgtagg tcgtcctc 28
 
<210> 8
<211> 28
<212> DNA
<213> artificial sequence
 
<400> 8
atagggacag tgtggctgac accatcac 28
 
<210> 9
<211> 30
<212> DNA
<213> artificial sequence
 
<400> 9
ctcaacatct cacgtgagat gctccagcag 30
 
<210> 10
<211> 30
<212> DNA
<213> artificial sequence
 
<400> 10
gttgtagtct tccttgttct cagcgatctc 30
 
<210> 11
<211> 32
<212> DNA
<213> artificial sequence
 
<400> 11
gctatgtacg tcgccatcca ggccgtcctc tc 32
 
<210> 12
<211> 31
<212> DNA
<213> artificial sequence
 
<400> 12
gagcatatcc ttcatagatg gggacagtgt g 31
 
<210> 13
<211> 35
<212> DNA
<213> artificial sequence
 
<400> 13
gccatcaggg cgtgatggtc ggcatgggac agaag 35
 
<210> 14
<211> 35
<212> DNA
<213> artificial sequence
 
<400> 14
ggcgacacgc agctcattgt agaaggtatg atgcc 35
 
<210> 15
<211> 32
<212> DNA
<213> artificial sequence
 
<400> 15
catcattcct gcctctactg gtgctgccaa ag 32
 
 
<210> 16
<211> 32
<212> DNA
<213> artificial sequence
 
<400> 16
gaccttttgc ttgatggctt catagcttgc ag 32
 
<210> 17
<211> 1737
<212> PRT
<213> artificial sequence
 
<400> 17
 
Met Gly Gln Thr Val Thr Thr Pro Leu Ser Leu Thr Leu Gly His Trp
1 5 10 15
 
Lys Asp Val Glu Arg Ile Ala His Asn Gln Ser Val Asp Val Lys Lys
20 25 30
 
Arg Arg Trp Val Thr Phe Cys Ser Ala Glu Trp Pro Thr Phe Asn Val
35 40 45
 
Gly Trp Pro Arg Asp Gly Thr Phe Asn Arg Asp Leu Ile Thr Gln Val
50 55 60
 
Lys Ile Lys Val Phe Ser Pro Gly Pro His Gly His Pro Asp Gln Val
65 70 75 80
 
Pro Tyr Ile Val Thr Trp Glu Ala Leu Ala Phe Asp Pro Pro Pro Trp
85 90 95
 
Val Lys Pro Phe Val His Pro Lys Pro Pro Pro Pro Leu Pro Pro Ser
100 105 110
 
Ala Pro Ser Leu Pro Leu Glu Pro Pro Arg Ser Thr Pro Pro Arg Ser
115 120 125
 
Ser Leu Tyr Pro Ala Leu Thr Pro Ser Leu Gly Ala Lys Pro Lys Pro
130 135 140
 
Gln Val Leu Ser Asp Ser Gly Gly Pro Leu Ile Asp Leu Leu Thr Glu
145 150 155 160
 
Asp Pro Pro Pro Tyr Arg Asp Pro Arg Pro Pro Pro Ser Asp Arg Asp
165 170 175
 
Gly Asn Gly Gly Glu Ala Thr Pro Ala Gly Glu Ala Pro Asp Pro Ser
180 185 190
 
Pro Met Ala Ser Arg Leu Arg Gly Arg Arg Glu Pro Pro Val Ala Asp
195 200 205
 
Ser Thr Thr Ser Gln Ala Phe Pro Leu Arg Ala Gly Gly Asn Gly Gln
210 215 220
 
Leu Gln Tyr Trp Pro Phe Ser Ser Ser Asp Leu Tyr Asn Trp Lys Asn
225 230 235 240
 
Asn Asn Pro Ser Phe Ser Glu Asp Pro Gly Lys Leu Thr Ala Leu Ile
245 250 255
 
Glu Ser Val Leu Ile Thr His Gln Pro Thr Trp Asp Asp Cys Gln Gln
260 265 270
 
Leu Leu Gly Thr Leu Leu Thr Gly Glu Glu Lys Gln Arg Val Leu Leu
275 280 285
 
Glu Ala Arg Lys Ala Val Arg Gly Asp Asp Gly Arg Pro Thr Gln Leu
290 295 300
 
Pro Asn Glu Val Asp Ala Ala Phe Pro Leu Glu Arg Pro Asp Trp Asp
305 310 315 320
 
Tyr Thr Thr Gln Ala Gly Arg Asn His Leu Val His Tyr Arg Gln Leu
325 330 335
 
Leu Leu Ala Gly Leu Gln Asn Ala Gly Arg Ser Pro Thr Asn Leu Ala
340 345 350
 
Lys Val Lys Gly Ile Thr Gln Gly Pro Asn Glu Ser Pro Ser Ala Phe
355 360 365
 
Leu Glu Arg Leu Lys Glu Ala Tyr Arg Arg Tyr Thr Pro Tyr Asp Pro
370 375 380
 
Glu Asp Pro Gly Gln Glu Thr Asn Val Ser Met Ser Phe Ile Trp Gln
385 390 395 400
 
Ser Ala Pro Asp Ile Gly Arg Lys Leu Glu Arg Leu Glu Asp Leu Lys
405 410 415
 
Asn Lys Thr Leu Gly Asp Leu Val Arg Glu Ala Glu Lys Ile Phe Asn
420 425 430
 
Lys Arg Glu Thr Pro Glu Glu Arg Glu Glu Arg Ile Arg Arg Glu Thr
435 440 445
 
Glu Glu Lys Glu Glu Arg Arg Arg Thr Glu Asp Glu Gln Lys Glu Lys
450 455 460
 
Glu Arg Asp Arg Arg Arg His Arg Glu Met Ser Lys Leu Leu Ala Thr
465 470 475 480
 
Val Val Ser Gly Gln Lys Gln Asp Arg Gln Gly Gly Glu Arg Arg Arg
485 490 495
 
Ser Gln Leu Asp Arg Asp Gln Cys Ala Tyr Cys Lys Glu Lys Gly His
500 505 510
 
Trp Ala Lys Asp Cys Pro Lys Lys Pro Arg Gly Pro Arg Gly Pro Arg
515 520 525
 
Pro Gln Thr Ser Leu Leu Thr Leu Asp Asp Gly Gly Gln Gly Gln Glu
530 535 540
 
Pro Pro Pro Glu Pro Arg Ile Thr Leu Lys Val Gly Gly Gln Pro Val
545 550 555 560
 
Thr Phe Leu Val Asp Thr Gly Ala Gln His Ser Val Leu Thr Gln Asn
565 570 575
 
Pro Gly Pro Leu Ser Asp Lys Ser Ala Trp Val Gln Gly Ala Thr Gly
580 585 590
 
Gly Lys Arg Tyr Arg Trp Thr Thr Asp Arg Lys Val His Leu Ala Thr
595 600 605
 
Gly Lys Val Thr His Ser Phe Leu His Val Pro Asp Cys Pro Tyr Pro
610 615 620
 
Leu Leu Gly Arg Asp Leu Leu Thr Lys Leu Lys Ala Gln Ile His Phe
625 630 635 640
 
Glu Gly Ser Gly Ala Gln Val Met Gly Pro Met Gly Gln Pro Leu Gln
645 650 655
 
Val Leu Thr Leu Asn Ile Glu Asp Glu His Arg Leu His Glu Thr Ser
660 665 670
 
Lys Glu Pro Asp Val Ser Leu Gly Ser Thr Trp Leu Ser Asp Phe Pro
675 680 685
 
Gln Ala Trp Ala Glu Thr Gly Gly Met Gly Leu Ala Val Arg Gln Ala
690 695 700
 
Pro Leu Ile Ile Pro Leu Lys Ala Thr Ser Thr Pro Val Ser Ile Lys
705 710 715 720
 
Gln Tyr Pro Met Ser Gln Glu Ala Arg Leu Gly Ile Lys Pro His Ile
725 730 735
 
Gln Arg Leu Leu Asp Gln Gly Ile Leu Val Pro Cys Gln Ser Pro Trp
740 745 750
 
Asn Thr Pro Leu Leu Pro Val Lys Lys Pro Gly Thr Asn Asp Tyr Arg
755 760 765
 
Pro Val Gln Asp Leu Arg Glu Val Asn Lys Arg Val Glu Asp Ile His
770 775 780
 
Pro Thr Val Pro Asn Pro Tyr Asn Leu Leu Ser Gly Leu Pro Pro Ser
785 790 795 800
 
His Gln Trp Tyr Thr Val Leu Asp Leu Lys Asp Ala Phe Phe Cys Leu
805 810 815
 
Arg Leu His Pro Thr Ser Gln Pro Leu Phe Ala Phe Glu Trp Arg Asp
820 825 830
 
Pro Glu Met Gly Ile Ser Gly Gln Leu Thr Trp Thr Arg Leu Pro Gln
835 840 845
 
Gly Phe Lys Asn Ser Pro Thr Leu Phe Asp Glu Ala Leu His Arg Asp
850 855 860
 
Leu Ala Asp Phe Arg Ile Gln His Pro Asp Leu Ile Leu Leu Gln Tyr
865 870 875 880
 
Val Asp Asp Leu Leu Leu Ala Ala Thr Ser Glu Leu Asp Cys Gln Gln
885 890 895
 
Gly Thr Arg Ala Leu Leu Gln Thr Leu Gly Asn Leu Gly Tyr Arg Ala
900 905 910
 
Ser Ala Lys Lys Ala Gln Ile Cys Gln Lys Gln Val Lys Tyr Leu Gly
915 920 925
 
Tyr Leu Leu Lys Glu Gly Gln Arg Trp Leu Thr Glu Ala Arg Lys Glu
930 935 940
 
Thr Val Met Gly Gln Pro Thr Pro Lys Thr Pro Arg Gln Leu Arg Glu
945 950 955 960
 
Phe Leu Gly Thr Ala Gly Phe Cys Arg Leu Trp Ile Pro Gly Phe Ala
965 970 975
 
Glu Met Ala Ala Pro Leu Tyr Pro Leu Thr Lys Thr Gly Thr Leu Phe
980 985 990
 
Asn Trp Gly Pro Asp Gln Gln Lys Ala Tyr Gln Glu Ile Lys Gln Ala
995 1000 1005
 
Leu Leu Thr Ala Pro Ala Leu Gly Leu Pro Asp Leu Thr Lys Pro
1010 1015 1020
 
Phe Glu Leu Phe Val Asp Glu Lys Gln Gly Tyr Ala Lys Gly Val
1025 1030 1035
 
Leu Thr Gln Lys Leu Gly Pro Trp Arg Arg Pro Val Ala Tyr Leu
1040 1045 1050
 
Ser Lys Lys Leu Asp Pro Val Ala Ala Gly Trp Pro Pro Cys Leu
1055 1060 1065
 
Arg Met Val Ala Ala Ile Ala Val Leu Thr Lys Asp Ala Gly Lys
1070 1075 1080
 
Leu Thr Met Gly Gln Pro Leu Val Ile Leu Ala Pro His Ala Val
1085 1090 1095
 
Glu Ala Leu Val Lys Gln Pro Pro Asp Arg Trp Leu Ser Asn Ala
1100 1105 1110
 
Arg Met Thr His Tyr Gln Ala Leu Leu Leu Asp Thr Asp Arg Val
1115 1120 1125
 
Gln Phe Gly Pro Val Val Ala Leu Asn Pro Ala Thr Leu Leu Pro
1130 1135 1140
 
Leu Pro Glu Glu Gly Leu Gln His Asn Cys Leu Asp Ile Leu Ala
1145 1150 1155
 
Glu Ala His Gly Thr Arg Pro Asp Leu Thr Asp Gln Pro Leu Pro
1160 1165 1170
 
Asp Ala Asp His Thr Trp Tyr Thr Asp Gly Ser Ser Leu Leu Gln
1175 1180 1185
 
Glu Gly Gln Arg Lys Ala Gly Ala Ala Val Thr Thr Glu Thr Glu
1190 1195 1200
 
Val Ile Trp Ala Lys Ala Leu Pro Ala Gly Thr Ser Ala Gln Arg
1205 1210 1215
 
Ala Glu Leu Ile Ala Leu Thr Gln Ala Leu Lys Met Ala Glu Gly
1220 1225 1230
 
Lys Lys Leu Asn Val Tyr Thr Asp Ser Arg Tyr Ala Phe Ala Thr
1235 1240 1245
 
Ala His Ile His Gly Glu Ile Tyr Arg Arg Arg Gly Leu Leu Thr
1250 1255 1260
 
Ser Glu Gly Lys Glu Ile Lys Asn Lys Asp Glu Ile Leu Ala Leu
1265 1270 1275
 
Leu Lys Ala Leu Phe Leu Pro Lys Arg Leu Ser Ile Ile His Cys
1280 1285 1290
 
Pro Gly His Gln Lys Gly His Ser Ala Glu Ala Arg Gly Asn Arg
1295 1300 1305
 
Met Ala Asp Gln Ala Ala Arg Lys Ala Ala Ile Thr Glu Thr Pro
1310 1315 1320
 
Asp Thr Ser Thr Leu Leu Ile Glu Asn Ser Ser Pro Tyr Thr Ser
1325 1330 1335
 
Glu His Phe His Tyr Thr Val Thr Asp Ile Lys Asp Leu Thr Lys
1340 1345 1350
 
Leu Gly Ala Ile Tyr Asp Lys Thr Lys Lys Tyr Trp Val Tyr Gln
1355 1360 1365
 
Gly Lys Pro Val Met Pro Asp Gln Phe Thr Phe Glu Leu Leu Asp
1370 1375 1380
 
Phe Leu His Gln Leu Thr His Leu Ser Phe Ser Lys Met Lys Ala
1385 1390 1395
 
Leu Leu Glu Arg Ser His Ser Pro Tyr Tyr Met Leu Asn Arg Asp
1400 1405 1410
 
Arg Thr Leu Lys Asn Ile Thr Glu Thr Cys Lys Ala Cys Ala Gln
1415 1420 1425
 
Val Asn Ala Ser Lys Ser Ala Val Lys Gln Gly Thr Arg Val Arg
1430 1435 1440
 
Gly His Arg Pro Gly Thr His Trp Glu Ile Asp Phe Thr Glu Ile
1445 1450 1455
 
Lys Pro Gly Leu Tyr Gly Tyr Lys Tyr Leu Leu Val Phe Ile Asp
1460 1465 1470
 
Thr Phe Ser Gly Trp Ile Glu Ala Phe Pro Thr Lys Lys Glu Thr
1475 1480 1485
 
Ala Lys Val Val Thr Lys Lys Leu Leu Glu Glu Ile Phe Pro Arg
1490 1495 1500
 
Phe Gly Met Pro Gln Val Leu Gly Thr Asp Asn Gly Pro Ala Phe
1505 1510 1515
 
al Ser Lys Val Ser Gln Thr Val Ala Asp Leu Leu Gly Ile Asp
1520 1525 1530
 
Trp Lys Leu His Cys Ala Tyr Arg Pro Gln Ser Ser Gly Gln Val
1535 1540 1545
 
Glu Arg Met Asn Arg Thr Ile Lys Glu Thr Leu Thr Lys Leu Thr
1550 1555 1560
 
Leu Ala Thr Gly Ser Arg Asp Trp Val Leu Leu Leu Pro Leu Ala
1565 1570 1575
 
Leu Tyr Arg Ala Arg Asn Thr Pro Gly Pro His Gly Leu Thr Pro
1580 1585 1590
 
Tyr Glu Ile Leu Tyr Gly Ala Pro Pro Pro Leu Val Asn Phe Pro
1595 1600 1605
 
Asp Pro Asp Met Thr Arg Val Thr Asn Ser Pro Ser Leu Gln Ala
1610 1615 1620
 
His Leu Gln Ala Leu Tyr Leu Val Gln His Glu Val Trp Arg Pro
1625 1630 1635
 
Leu Ala Ala Ala Tyr Gln Glu Gln Leu Asp Arg Pro Val Val Pro
1640 1645 1650
 
His Pro Tyr Arg Val Gly Asp Thr Val Trp Val Arg Arg His Gln
1655 1660 1665
 
Thr Lys Asn Leu Glu Pro Arg Trp Lys Gly Pro Tyr Thr Val Leu
1670 1675 1680
 
Leu Thr Thr Pro Thr Ala Leu Lys Val Asp Gly Ile Ala Ala Trp
1685 1690 1695
 
Ile His Ala Ala His Val Lys Ala Ala Asp Pro Gly Gly Gly Pro
1700 1705 1710
 
Ser Ser Arg Leu Thr Trp Arg Val Gln Arg Ser Gln Asn Pro Leu
1715 1720 1725
 
Lys Ile Arg Leu Thr Arg Glu Ala Pro
1730 1735
 
<210> 18
<211> 393
<212> PRT
<213> artificial sequence
 
<400> 18
 
Met Ser Ile Ala Asp Leu Lys Ser Arg Leu Ile Lys Ala Ser Thr Ser
1 5 10 15
 
Lys Met Thr Ala Glu Leu Thr Thr Ser Lys Phe Phe Asn Glu Lys Asp
20 25 30
 
Val Ile Arg Thr Lys Ile Pro Met Leu Asn Ile Ala Ile Ser Gly Ala
35 40 45
 
Ile Asp Gly Gly Met Gln Ser Gly Leu Thr Ile Phe Ala Gly Pro Ser
50 55 60
 
Lys His Phe Lys Ser Asn Met Ser Leu Thr Met Val Ala Ala Tyr Leu
65 70 75 80
 
Asn Lys Tyr Pro Asp Ala Val Cys Leu Phe Tyr Asp Ser Glu Phe Gly
85 90 95
 
Ile Thr Pro Ala Tyr Leu Arg Ser Met Gly Val Asp Pro Glu Arg Val
100 105 110
 
Ile His Thr Pro Ile Gln Ser Val Glu Gln Leu Lys Ile Asp Met Val
115 120 125
 
Asn Gln Leu Glu Ala Ile Glu Arg Gly Glu Lys Val Ile Val Phe Ile
130 135 140
 
Asp Ser Ile Gly Asn Met Ala Ser Lys Lys Glu Thr Glu Asp Ala Leu
145 150 155 160
 
Asn Glu Lys Ser Val Ala Asp Met Thr Arg Ala Lys Ser Leu Lys Ser
165 170 175
 
Leu Phe Arg Ile Val Thr Pro Tyr Phe Ser Leu Lys Asn Ile Pro Cys
180 185 190
 
Val Ala Val Asn His Thr Ile Glu Thr Ile Glu Met Phe Ser Lys Thr
195 200 205
 
Val Met Thr Gly Gly Thr Gly Val Met Tyr Ser Ala Asp Thr Val Phe
210 215 220
 
Ile Ile Gly Lys Arg Gln Ile Lys Asp Gly Ser Asp Leu Gln Gly Tyr
225 230 235 240
 
Gln Phe Val Leu Asn Val Glu Lys Ser Arg Thr Val Lys Glu Lys Ser
245 250 255
 
Lys Phe Phe Ile Asp Val Lys Phe Asp Gly Gly Ile Asp Pro Tyr Ser
260 265 270
 
Gly Leu Leu Asp Met Ala Leu Glu Leu Gly Phe Val Val Lys Pro Lys
275 280 285
 
Asn Gly Trp Tyr Ala Arg Glu Phe Leu Asp Glu Glu Thr Gly Glu Met
290 295 300
 
Ile Arg Glu Glu Lys Ser Trp Arg Ala Lys Asp Thr Asn Cys Thr Thr
305 310 315 320
 
Phe Trp Gly Pro Leu Phe Lys His Gln Pro Phe Arg Asp Ala Ile Lys
325 330 335
 
Arg Ala Tyr Gln Leu Gly Ala Ile Asp Ser Asn Glu Ile Val Glu Ala
340 345 350
 
Glu Val Asp Glu Leu Ile Asn Ser Lys Val Glu Lys Phe Lys Ser Pro
355 360 365
 
Glu Ser Lys Ser Lys Ser Ala Ala Asp Leu Glu Thr Asp Leu Glu Gln
370 375 380
 
Leu Ser Asp Met Glu Glu Phe Asn Glu
385 390
 
<210> 19
<211> 298
<212> PRT
<213> artificial sequence
 
<400> 19
 
Met Phe Lys Arg Lys Ser Thr Ala Asp Leu Ala Ala Gln Met Ala Lys
1 5 10 15
 
Leu Asn Gly Asn Lys Gly Phe Ser Ser Glu Asp Lys Gly Glu Trp Lys
20 25 30
 
Leu Lys Leu Asp Ala Ser Gly Asn Gly Gln Ala Val Ile Arg Phe Leu
35 40 45
 
Pro Ala Lys Thr Asp Asp Ala Leu Pro Phe Ala Ile Leu Val Asn His
50 55 60
 
Gly Phe Lys Lys Asn Gly Lys Trp Tyr Ile Glu Thr Cys Ser Ser Thr
65 70 75 80
 
His Gly Asp Tyr Asp Ser Cys Pro Val Cys Gln Tyr Ile Ser Lys Asn
85 90 95
 
Asp Leu Tyr Asn Thr Asn Lys Thr Glu Tyr Ser Gln Leu Lys Arg Lys
100 105 110
 
Thr Ser Tyr Trp Ala Asn Ile Leu Val Val Lys Asp Pro Gln Ala Pro
115 120 125
 
Asp Asn Glu Gly Lys Val Phe Lys Tyr Arg Phe Gly Lys Lys Ile Trp
130 135 140
 
Asp Lys Ile Asn Ala Met Ile Ala Val Asp Thr Glu Met Gly Glu Thr
145 150 155 160
 
Pro Val Asp Val Thr Cys Pro Trp Glu Gly Ala Asn Phe Val Leu Lys
165 170 175
 
Val Lys Gln Val Ser Gly Phe Ser Asn Tyr Asp Glu Ser Lys Phe Leu
180 185 190
 
Asn Gln Ser Ala Ile Pro Asn Ile Asp Asp Glu Ser Phe Gln Lys Glu
195 200 205
 
Leu Phe Glu Gln Met Val Asp Leu Ser Glu Met Thr Ser Lys Asp Lys
210 215 220
 
Phe Lys Ser Phe Glu Glu Leu Asn Thr Lys Phe Asn Gln Val Leu Gly
225 230 235 240
 
Thr Ala Ala Leu Gly Gly Ala Ala Ala Ala Ala Ala Ser Val Ala Asp
245 250 255
 
Lys Val Ala Ser Asp Leu Asp Asp Phe Asp Lys Asp Met Glu Ala Ser
260 265 270
 
Ser Ala Lys Thr Glu Asp Asp Phe Met Ser Ser Ser Ser Ser Asp Asp
275 280 285
 
Gly Asp Leu Asp Asp Leu Leu Ala Gly Leu
290 295
 
<210> 20
<211> 876
<212> PRT
<213> artificial sequence
 
<400> 20
 
Val Asn Lys Leu Val Leu Ile Asp Gly Asn Ser Leu Ser Phe Arg Ala
1 5 10 15
 
Phe Tyr Ala Leu Pro Leu Leu Ser Asn Lys Ala Gly Ile His Thr Asn
20 25 30
 
Ala Val Tyr Gly Phe Ala Met Leu Leu Glu Lys Ile Leu Lys Glu Glu
35 40 45
 
Lys Pro Asn His Phe Leu Val Ala Phe Asp Ala Gly Lys Thr Thr Phe
50 55 60
 
Arg His Glu Lys Tyr Ser Glu Tyr Lys Gly Gly Arg Gln Lys Thr Pro
65 70 75 80
 
Pro Glu Leu Ser Glu Gln Phe Pro Tyr Ile Arg Gln Leu Leu Asp Ala
85 90 95
 
Tyr His Ile Lys Arg Tyr Glu Leu Asp Asn Tyr Glu Ala Asp Asp Ile
100 105 110
 
Ile Gly Thr Leu Ser Lys Glu Ala Asp Lys Ala Gly Phe Gln Thr Ile
115 120 125
 
Ile Ile Thr Gly Asp Arg Asp Leu Thr Gln Leu Ala Thr Asp Asn Val
130 135 140
 
Thr Ile Tyr Tyr Thr Lys Lys Gly Val Thr Asp Val Asp His Tyr Thr
145 150 155 160
 
Pro Asp Phe Ile Ala Glu Lys Tyr Asn Gly Lys Thr Pro Asn Gln Ile
165 170 175
 
Ile Asp Met Lys Gly Leu Met Gly Asp Thr Ser Asp Asn Ile Pro Gly
180 185 190
 
Val Ala Gly Val Gly Glu Lys Thr Ala Ile Lys Leu Leu Asn Gln Phe
195 200 205
 
Asp Thr Val Glu Gly Val Tyr Glu His Leu Asp Glu Ile Ser Gly Lys
210 215 220
 
Lys Leu Lys Glu Lys Leu Gln Asn Ser Lys Glu Asp Ala Leu Met Ser
225 230 235 240
 
Lys Glu Leu Ala Thr Ile Asn Val Asp Ser Pro Ile Glu Val Lys Leu
245 250 255
 
Glu Asp Thr Leu Met Thr His Gln Asp Glu Gln Gln Glu Lys Ile Glu
260 265 270
 
 
Leu Phe Lys Lys Leu Glu Phe Lys Gln Leu Leu Ala Asp Ile Asp Gln
275 280 285
 
Ser Ala Ser Val Glu Asp Ala Ile Glu Lys Thr Phe Glu Ile Glu Thr
290 295 300
 
Ser Phe Asp Asn Ile Asp Phe Thr Ser Leu Lys Glu Ala Ala Ile His
305 310 315 320
 
Phe Glu Leu Asp Gly Gly Asn Tyr Leu Arg Asn Asn Ile Leu Lys Phe
325 330 335
 
Ser Leu Phe Thr Gly Glu Lys His Ile Val Ile Asn Ala Asp Asp Ile
340 345 350
 
Asn Asn Tyr Val Glu Leu Val Ser Trp Leu Glu Asn Pro Asn Ser Lys
355 360 365
 
Lys Val Val Tyr Asp Ala Lys Lys Thr Tyr Val Ala Ser His Arg Leu
370 375 380
 
Gly Ile Asp Ile Gln Asn Ile Ser Phe Asp Ile Met Leu Ala Ser Tyr
385 390 395 400
 
Ile Ile Asp Pro Ser Arg Thr Ile Ser Asp Val Gln Ser Val Val Ser
405 410 415
 
Leu Tyr Gly Gln Ser Phe Val Lys Asp Asp Val Ser Ile Tyr Gly Lys
420 425 430
 
Gly Lys Lys Phe Lys Val Pro Glu Asp Asp Val Leu Asn Pro Tyr Val
435 440 445
 
Ala Ser Ile Thr Asp Ala Ile Tyr Phe Ala Lys Pro Asn Met Asp Lys
450 455 460
 
Gln Leu Glu Glu Tyr Asn Gln Val Glu Leu Leu Ala Asp Leu Glu Leu
465 470 475 480
 
Pro Leu Ala Lys Ile Leu Ser Glu Met Glu Glu Ile Gly Ile Phe Thr
485 490 495
 
Asp Val His Asp Leu Glu Glu Met Glu Lys Glu Ile Gln Glu Lys Leu
500 505 510
 
Asp Val Leu Ile Arg Asn Ile His Asp Ala Ala Gly Glu Asp Phe Asn
515 520 525
 
Ile Asn Ser Pro Lys Gln Leu Gly Val Val Leu Phe Glu Thr Leu Gln
530 535 540
 
Leu Pro Val Ile Lys Lys Thr Lys Thr Gly Tyr Ser Thr Ala Val Asp
545 550 555 560
 
Val Leu Glu Gln Leu Gln Gly Glu His Pro Ile Ile Asp Tyr Ile Leu
565 570 575
 
Glu Tyr Arg Gln Leu Ser Lys Leu Gln Ser Thr Tyr Val Glu Gly Leu
580 585 590
 
Gln Lys Val Ile Ser Asp Asp Gln Arg Ile His Thr Arg Phe Asn Gln
595 600 605
 
Thr Leu Ala Gln Thr Gly Arg Leu Ser Ser Val Asp Pro Asn Leu Gln
610 615 620
 
Asn Ile Pro Val Arg Leu Glu Glu Gly Arg Lys Ile Arg Lys Ala Phe
625 630 635 640
 
Lys Pro Thr Ser Lys Asp Ser Val Ile Leu Ser Ala Asp Tyr Ser Gln
645 650 655
 
Ile Glu Leu Arg Val Leu Ala His Ile Thr Gln Asp Glu Ser Met Lys
660 665 670
 
Glu Ala Phe Ile Asn Gly Asp Asp Ile His Thr Ala Thr Ala Met Lys
675 680 685
 
Val Phe Gly Val Glu Ala Asp Gln Val Asp Ser Leu Met Arg Arg Gln
690 695 700
 
Ala Lys Ala Val Asn Phe Gly Ile Val Tyr Gly Ile Ser Asp Tyr Gly
705 710 715 720
 
Leu Ser Gln Ser Leu Gly Ile Thr Arg Lys Lys Ala Lys Ala Phe Ile
725 730 735
 
Asp Asp Tyr Leu Ala Ser Phe Pro Gly Val Lys Gln Tyr Met Ser Asp
740 745 750
 
Ile Val Lys Asp Ala Lys Ala Leu Gly Tyr Val Glu Thr Leu Leu His
755 760 765
 
Arg Arg Arg Tyr Ile Pro Asp Ile Thr Ser Arg Asn Phe Asn Leu Arg
770 775 780
 
Gly Phe Ala Glu Arg Thr Ala Met Asn Thr Pro Ile Gln Gly Ser Ala
785 790 795 800
 
Ala Asp Ile Ile Lys Leu Ala Met Val Lys Phe Ala Gln Lys Met Lys
805 810 815
 
Glu Thr Thr Tyr Gln Ala Lys Leu Leu Leu Gln Val His Asp Glu Leu
820 825 830
 
Ile Phe Glu Val Pro Lys Ser Glu Val Asp Ser Phe Ser Glu Phe Val
835 840 845
 
Glu Glu Ile Met Glu Asn Ala Leu Gln Leu Asp Val Pro Leu Lys Val
850 855 860
 
Asp Ser Ser Tyr Gly Ala Thr Trp Tyr Asp Ala Lys
865 870 875
 
<210> 21
<211> 140
<212> PRT
<213> artificial sequence
 
<400> 21
 
Met Arg Leu Glu Asp Leu Gln Glu Glu Leu Lys Lys Asp Val Phe Ile
1 5 10 15
 
Asp Ser Thr Lys Leu Gln Tyr Glu Ala Ala Asn Asn Val Met Leu Tyr
20 25 30
 
Ser Lys Trp Leu Asn Lys His Ser Ser Ile Lys Lys Glu Met Leu Arg
35 40 45
 
Ile Glu Ala Gln Lys Lys Val Ala Leu Lys Ala Arg Leu Asp Tyr Tyr
50 55 60
 
Ser Gly Arg Gly Asp Gly Asp Glu Phe Ser Met Asp Arg Tyr Glu Lys
65 70 75 80
 
Ser Glu Met Lys Thr Val Leu Ser Ala Asp Lys Asp Val Leu Lys Val
85 90 95
 
Asp Thr Ser Leu Gln Tyr Trp Gly Ile Leu Leu Asp Phe Cys Ser Glu
100 105 110
 
Leu Leu Met Leu Leu Asn His Val Asp Leu Leu Leu Ser Ile Phe Lys
115 120 125
 
Thr Cys Glu His Leu Arg Leu Gln Asn Asn Glu Ile
130 135 140

Claims (7)

1. for the proteolytic enzyme of normal temperature isothermal rapid detection Yeast Nucleic Acid, it is characterized in that, described proteolytic enzyme comprises: (1) reversed transcriptive enzyme; (2) recombinase; (3) single strand binding protein; (4) archaeal dna polymerase; (5) accessory protein; The aminoacid sequence of described reversed transcriptive enzyme is as shown in SEQ ID No.17; The aminoacid sequence of recombinase is as shown in SEQ ID No.18; The aminoacid sequence of single strand binding protein is as shown in SEQ ID No.19; The aminoacid sequence of archaeal dna polymerase is as shown in SEQ ID No.20; The aminoacid sequence of accessory protein is as shown in SEQ ID No.21.
2. proteolytic enzyme as claimed in claim 1, it is characterized in that, in amplification system, reverse transcriptase concentrations scope is 8-12 unit/ul; Recombinase concentration range is 100-150ng/ul; Single strand binding protein concentration range is 700-1000ng/ul; Archaeal dna polymerase concentration range is 60-90ng/ul; Accessory protein concentration range is 20-40ng/ul.
3. for the reagent of normal temperature isothermal rapid detection Yeast Nucleic Acid, it is characterized in that, described reagent mainly comprises Tris, RNase inhibitor, dNTP, ATP, disodium creatine phosphate, creatine phosphokinase, potassium acetate, trehalose, N.F,USP MANNITOL, polyoxyethylene glycol, dithiothreitol (DTT), amplimer and proteolytic enzyme according to claim 1.
4. reagent as claimed in claim 3, it is characterized in that, described reagent comprises: 5%PEG35000,6% trehalose, the recombinase of 115ng/ul, the accessory protein of 35ng/ul, the single strand binding protein of 830ng/ul, the Bsu polysaccharase of 78ng/ul, the reversed transcriptive enzyme of 12 units/ul, the RNase inhibitor of 0.15 unit/ul, the ATP of 3.5mM, the dNTPs of 490uM, the Tris damping fluid of 55mM, the dithiothreitol (DTT) of 12mM, the disodium creatine phosphate of 12mM, the creatine phosphokinase of 114ng/ul, the potassium acetate of 75mM and 7% N.F,USP MANNITOL; The amplimer of 350-450nM; Cumulative volume is 50ul.
5. reagent as claimed in claim 4, is characterized in that, described reagent, through lyophilize process, removes liquid phase, retains solid matter, makes white dry powder.
6. a method for normal temperature isothermal rapid detection Yeast Nucleic Acid, is characterized in that, after detection reagent adds template, being placed in a temperature control device, to maintain incubation temperature be 40-42 DEG C, hatches 20-40 minute, hatch in process and keep homogeneous steady temperature; Visual retrieval is carried out again by agarose gel electrophoresis; Described detection reagent mainly comprises Tris, RNase inhibitor, dNTP, ATP, disodium creatine phosphate, creatine phosphokinase, potassium acetate, trehalose, N.F,USP MANNITOL, polyoxyethylene glycol, dithiothreitol (DTT), amplimer and proteolytic enzyme according to claim 1.
7. amplification method as claimed in claim 6, described incubation temperature is 40 DEG C.
CN201510229119.0A 2015-05-07 2015-05-07 Protease and detection method for rapidly detecting ribonucleic acid at constant room temperature Pending CN104830820A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510229119.0A CN104830820A (en) 2015-05-07 2015-05-07 Protease and detection method for rapidly detecting ribonucleic acid at constant room temperature

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510229119.0A CN104830820A (en) 2015-05-07 2015-05-07 Protease and detection method for rapidly detecting ribonucleic acid at constant room temperature

Publications (1)

Publication Number Publication Date
CN104830820A true CN104830820A (en) 2015-08-12

Family

ID=53809020

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510229119.0A Pending CN104830820A (en) 2015-05-07 2015-05-07 Protease and detection method for rapidly detecting ribonucleic acid at constant room temperature

Country Status (1)

Country Link
CN (1) CN104830820A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107119137A (en) * 2017-05-26 2017-09-01 广州华弘生物科技有限公司 A kind of detection kit and detection method of quick detection HER 2/neu gene expressions
CN108179177A (en) * 2017-12-29 2018-06-19 博迪泰(厦门)生物科技有限公司 A kind of kit and detection method of quick detection nucleic acid mutation
CN110643687A (en) * 2019-11-19 2020-01-03 深圳市艾伟迪生物科技有限公司 SRDA (sequence-related amplified deoxyribonucleic acid) isothermal nucleic acid amplification kit and application thereof
CN111500687A (en) * 2020-05-12 2020-08-07 深圳市草履虫生物科技有限公司 Breast cancer 21 gene detection kit
CN112239754A (en) * 2020-09-09 2021-01-19 北京盛因生物科技有限公司 Isothermal nucleic acid amplification method and application

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440730B1 (en) * 1998-11-26 2002-08-27 Heinrich-Pette-Institut Retroviral hybrid vectors pseudotyped with LCMV
CN101591703B (en) * 2008-11-22 2011-11-02 中国水产科学研究院黄海水产研究所 Preservation method of loop-mediated isothermal amplification reaction reagent mixture
CN102703427B (en) * 2012-06-01 2013-11-06 中国水产科学研究院黄海水产研究所 Gel-based preservation method for nucleic acid isothermal amplification reagent
CN103476940A (en) * 2011-04-07 2013-12-25 美艾利尔圣地亚哥有限公司 Monitoring recombinase polymerase amplification mixtures
CN103014148B (en) * 2012-10-29 2014-03-12 中国科学院成都生物研究所 Isothermal detection method of RNA (Ribonucleic Acid)

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440730B1 (en) * 1998-11-26 2002-08-27 Heinrich-Pette-Institut Retroviral hybrid vectors pseudotyped with LCMV
CN101591703B (en) * 2008-11-22 2011-11-02 中国水产科学研究院黄海水产研究所 Preservation method of loop-mediated isothermal amplification reaction reagent mixture
CN103476940A (en) * 2011-04-07 2013-12-25 美艾利尔圣地亚哥有限公司 Monitoring recombinase polymerase amplification mixtures
CN102703427B (en) * 2012-06-01 2013-11-06 中国水产科学研究院黄海水产研究所 Gel-based preservation method for nucleic acid isothermal amplification reagent
CN103014148B (en) * 2012-10-29 2014-03-12 中国科学院成都生物研究所 Isothermal detection method of RNA (Ribonucleic Acid)

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
NCBI: "DNA polymerase I [Staphylococcus aureus]", 《GENBANK DATABASE》 *
NCBI: "RecA-like recombinase protein [Enterobacteria phage vB_EcoM_ACG-C40]", 《GENBANK DATABASE》 *
PETROV,V.等: "single-stranded DNA binding protein [Enterobacteria phage RB69]", 《GENBANK DATABASE》 *
TAKAHASHI,H.等: "uvsY protein [Enterobacteria phage T4]", 《GENBANK DATABASE》 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107119137A (en) * 2017-05-26 2017-09-01 广州华弘生物科技有限公司 A kind of detection kit and detection method of quick detection HER 2/neu gene expressions
CN108179177A (en) * 2017-12-29 2018-06-19 博迪泰(厦门)生物科技有限公司 A kind of kit and detection method of quick detection nucleic acid mutation
CN110643687A (en) * 2019-11-19 2020-01-03 深圳市艾伟迪生物科技有限公司 SRDA (sequence-related amplified deoxyribonucleic acid) isothermal nucleic acid amplification kit and application thereof
CN111500687A (en) * 2020-05-12 2020-08-07 深圳市草履虫生物科技有限公司 Breast cancer 21 gene detection kit
CN112239754A (en) * 2020-09-09 2021-01-19 北京盛因生物科技有限公司 Isothermal nucleic acid amplification method and application

Similar Documents

Publication Publication Date Title
US10683498B2 (en) Methods for generating circular DNA from circular RNA
US10954557B2 (en) Methods for processing nucleic acid samples
US9528137B2 (en) Methods for cell-free protein synthesis
CN104830820A (en) Protease and detection method for rapidly detecting ribonucleic acid at constant room temperature
KR102435352B1 (en) Ligase-assisted nucleic acid circularization and amplification
JP2019531710A5 (en)
US20130130919A1 (en) Long-Range Barcode Labeling-Sequencing
JP7013069B2 (en) Isothermal amplification under low salt conditions
JP6249947B2 (en) Compositions and methods for RT-PCR comprising anionic polymers
CN106834508A (en) The method that the hyper-branched rolling circle amplification that a kind of coupled reaction triggers detects miRNA
US20170362623A1 (en) Amplification of nucleic acids
CN105112399A (en) Fluorescent constant-temperature amplification technique
WO2016135300A1 (en) Efficiency improving methods for gene library generation
CA3024546A1 (en) Method of amplifying circular dna
KR102014989B1 (en) Polynucleotide and use thereof
WO2018014799A1 (en) Recombinase polymerase amplification reagent kit, amplification method, and amplification reagent
WO2023093060A1 (en) Reverse-transcription amplification system and method based on recombinase polymerase amplification technology
WO2023093061A1 (en) Method for preparing constant-temperature amplification mixed enzyme system
CN104818263A (en) Protease used for normal- and constant-temperature nucleic acid large fragment in-vitro amplification and amplification method
US20160355870A1 (en) Generation of ligation-ready dna amplicons
KR20130062296A (en) Method for synthesizing cdna
JP5129498B2 (en) Nucleic acid cloning method
US20180080070A1 (en) Method for template-dependent multiple displacement amplification
Gadkar et al. A linear concatenation strategy to construct 5′-enriched amplified cDNA libraries using multiple displacement amplification
WO2023140731A1 (en) Thermostable rna polymerase

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
EXSB Decision made by sipo to initiate substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20150812